SBRI Healthcare
SBRI Healthcare provides funding and support to early-stage projects, enabling testing for business feasibility and technology development as well as to more mature products by supporting real-world implementation studies.
The competitions aim to accelerate innovative technologies in the NHS and the wider health and social care system, tackling unmet health and care needs.
Funding is available for phase 1 and 3 of the competition, looking for innovations that can help stroke services, urgent and emergency care, women’s health and Antimicrobial Resistance (AMR).
Competition 26 – Urgent & emergency care and stroke
Applications close 18 September 2024, 1pm. Projects are scheduled to start between January and February 2025. Contracts will last up to 12 months and are valued at up to £500,000 (NET) per project.
Find out more on the SBRI website.
Women Tech EU
Deadline: 3 September 2024
A €12 million, 2-year EU-funded project aimed at supporting women leading deep tech startups across Europe. Their goal is to foster a gender-balanced entrepreneurship ecosystem by offering 160 selected startups €75k grants (non-dilutive finance) each, along with a comprehensive business development program encompassing mentoring and training.
Behavioural overweight and obesity management interventions that include long term support in achieving and maintaining weight loss in children and young people
Deadline 13 December 2024, 13:00
The Public Health Research (PHR) Programme is accepting stage 1 applications to their commissioned workstream for this topic.
A webinar will be held on Wednesday 9 October 2024, 11:15 – 12:30pm to support applications for this funding opportunity.
BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL:
Biotechnology and Biological Sciences Research Council, part of UK Research and Innovation, is a non-departmental public body, and is the largest UK public funder of non-medical bioscience. It predominantly funds scientific research institutes and university research departments in the UK.
BBSRC standard research grant Deadline: Open call
You can apply for research grants at any time in any area within the remit of BBSRC. BBSRC funds research in plants, microbes, animals (including humans), and the tools and technology underpinning biological research from the level of molecules and cells, to tissues, whole organisms, populations and landscapes.
NIHR Funding Calls
The National Institute for Health and Care Research is the British government’s major funder of clinical, public health, social care and translational research. Its mission is to “improve the health and wealth of the nation through research”.
NIHR i4i Launch dates: Product Development Award
i4i Product Development Awards (PDA) support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system. The expected focus of a PDA is product development required to enable a technology for clinical use or use in social care and/or the clinical development of a laboratory-validated technology or intervention. The research proposals may address any area of unmet need. Projects must have a clear pathway towards adoption and commercialisation.
Product Development Award Call 29: Launch 10 October 2024 / Deadline: 5th December 2024.
Technology-Enabled Social Care
Deadline: 30 October 2024
Under its highlight notice call, “Technology-Enabled Social Care”, the NIHR Research Programme for Social Care (RPSC) is inviting proposals for collaborative research projects that examine the development and utilisation of digital technology in social care.
The Health Technology Assessment (HTA) Programme is accepting Stage 1 applications to their commissioned workstream for this primary research topic.
In order to apply you will need to carefully review the:
Applications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a Stage 2 application. Applicants will have 8 weeks to complete and submit their Stage 2 application form, which will then be considered at the following HTA funding committee meeting. For more information, please read the commissioning brief.
All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.
Studies within a trial or review
This funding opportunity is eligible for a SWAT/SWAR (study within a trial or study within a review), which can help significantly improve methodology of future research as well as the host study. Find out about the benefits of SWATs/SWARs and how to include one in your application.
24/70 Earlier stopping of NAC following paracetamol overdose
Opens
05 August 2024
Closes
1pm on 27 November 2024
24/82 Comparing surgery to conservative management for the treatment of tennis elbow with persistent symptoms
Opens
05 August 2024
Closes
1pm on 27 November 2024
Charitable Awards
Versus Arthritis
Oliver Bird Fund Round 3
This funding round is a partnership with the Nuffield Foundation. More information on how to apply can be found on the Nuffield Foundation website.
Up to £750,000 for up to 48 months funding (open to extending with discussion)
Deadline for applications: 16 September 2024 (outline) and January 2025 (Full)
Clinical Epidemiology Research Consortium 2025
Consortium funding aims to unlock area(s) of problematic understanding around disease and treatment.
Up to £3 million for up to 60 months.
Deadline for applications: 16:00 Wednesday 25th September 2024
Inflammatory Arthritis Research Consortium 2025
Versus Arthritis seeks to support team science working ‘across and together’ to bring integrated thought and ambition toward unlocking a problem area at pace – creating a community of shared expertise and knowledge to deliver a cohesive series of research to achieve the aims.
Up to £3 million for up to 60 months.
Deadline for applications: 16:00 Wednesday 25th September 2024